Log in
Enquire now
‌

US Patent 10201710 Latency-based adaptation of anti-tachyarrhythmia pacing therapy

Patent 10201710 was granted and assigned to Medtronic on February, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Medtronic
Medtronic
Current Assignee
Medtronic
Medtronic
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10201710
Date of Patent
February 12, 2019
Patent Application Number
15141741
Date Filed
April 28, 2016
Patent Citations Received
‌
US Patent 11260216 Methods and systems for detecting atrial contraction timing fiducials during ventricular filling from a ventricularly implanted leadless cardiac pacemaker
‌
US Patent 11065459 Implantable medical device with pressure sensor
‌
US Patent 11071870 Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker
‌
US Patent 11633112 Automatic alert control for acute health event
0
‌
US Patent 10561330 Implantable medical device having a sense channel with performance adjustment
‌
US Patent 11529523 Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone
‌
US Patent 11235163 Implantable medical device with multiple modes of operation
‌
US Patent 10821288 Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate
...
Patent Primary Examiner
‌
Lindsey G Wehrheim
Patent abstract

An implantable medical device comprises therapy delivery circuitry and processing circuitry. The therapy delivery circuitry is configured to deliver anti-tachycardia pacing (ATP) therapy to a heart of a patient. The ATP therapy includes one or more pulse trains and each of the one or more pulse trains includes a plurality of pacing pulses. The processing circuitry is configured to, for at least one of the plurality of pacing pulses of at least one of the one or more pulse trains, determine at least one latency metric of an evoked response of the heart to the pacing pulse. The processing circuitry is further configured to modify the ATP therapy based on the at least one latency metric.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10201710 Latency-based adaptation of anti-tachyarrhythmia pacing therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.